The Akt and ERK activation by platinum-based chemotherapy in ovarian cancer is associated with favorable patient outcome. (Q43208984)

From Wikidata
Jump to navigation Jump to search
scientific article published in November 2009
edit
Language Label Description Also known as
English
The Akt and ERK activation by platinum-based chemotherapy in ovarian cancer is associated with favorable patient outcome.
scientific article published in November 2009

    Statements

    The Akt and ERK activation by platinum-based chemotherapy in ovarian cancer is associated with favorable patient outcome (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit